Target intelligence / Profile preview

NRG1 intronic transcript 3 (non-protein coding) (NRG1-IT3)

Target
NRG1-IT3
Molecular classification
Other, Non-coding RNA (long non-coding RNA, based on annotation[5])
01

Overview

NRG1 intronic transcript 3 (NRG1-IT3) is a non-protein-coding RNA transcript transcribed from an intronic region of the *Neuregulin 1* (*NRG1*) gene. This transcript does not encode a protein and there is no published experimental evidence about its function, disease role, or relevance as a drug target. It is not considered a canonical therapeutic target, and there is no indication of its use in biomarker assays, drug discovery, or clinical practice. Its entry in gene annotation databases appears to be based on RNA-seq or genome annotation, not on demonstrated biological or clinical importance[5]. *Note:* If you are seeking information on protein-coding NRG1 isoforms (such as Neuregulin 1 type III), these have important, experimentally supported roles in cell signaling and neurological/oncological diseases[1][2][3][4], but NRG1-IT3 is distinct and currently has no such accepted function or target designation.

Other names
NRG1-IT3NRG1 intronic transcript 3 (non-protein coding)
02

Mechanism of action

None

03

Biological functions

UnknownNo experimentally validated biological function is reported in databases or literature for NRG1-IT3 itself.
04

Disease associations

None establishedNo direct associations with disease roles specific to this transcript.
05

Safety considerations

Not applicableNo clinical relevance or safety profile described for this transcript.
06

Interacting drugs

None

1 more in the full profile.

07

Biomarkers

None establishedNRG1-IT3 is not used as a biomarker for patient selection, disease, or therapy monitoring.

Beyond the preview

Go deeper on NRG1 intronic transcript 3 (non-protein coding) (NRG1-IT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NRG1 intronic transcript 3 (non-protein coding) (NRG1-IT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call